Internal Medicine, Gastroenterology · Charlotte, NC
NPI
1326066705
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
101 E Wt Harris Blvd Ste 3111
Charlotte, NC, 28262
Phone (704) 547-8818
Groups this clinician bills Medicare through
Medicare paid, 2024
$198K
3,268 services
Medicare patients, 2024
553
Average age 73
Drug cost, 2024
$4.3M
5,736 prescriptions
Company payments, 2025
$235K
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Fred C Fowler was code 99439 (chronic, principal, and transitional care management), 1,340 times for 114 patients. In total Fred C Fowler billed 3,268 services in 45 codes, and Medicare paid $198K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-01-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99439 Chronic, Principal, and Transitional Care Management | Office | 1,340 | 114 | $37.67 | $50K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 737 | 117 | $48.67 | $36K |
| 99214 Office E&M - Established | Office | 241 | 171 | $89.31 | $22K |
| 43239 Upper GI Endoscopy | Facility | 142 | 138 | $56.65 | $8,045 |
| 99457 E&M - Miscellaneous | Office | 127 | 24 | $38.70 | $4,915 |
| 45385 Colonoscopy - Lesion Removal | Facility | 120 | 120 | $204.45 | $25K |
| 99204 Office E&M - New | Office | 119 | 119 | $113.23 | $13K |
| 45380 Lower GI Endoscopy - Other | Facility | 81 | 81 | $115.89 | $9,387 |
| 99454 E&M - Miscellaneous | Office | 79 | 22 | $36.03 | $2,846 |
| 99231 Hospital E&M - Subsequent | Facility | 62 | 37 | $39.83 | $2,469 |
| 43249 Upper GI Endoscopy | Facility | 34 | 32 | $95.14 | $3,235 |
| 99222 Hospital E&M - Initial | Facility | 32 | 30 | $103.26 | $3,304 |
| 99221 Hospital E&M - Initial | Facility | 26 | 26 | $66.39 | $1,726 |
| 99213 Office E&M - Established | Office | 20 | 19 | $66.76 | $1,335 |
| 43248 Upper GI Endoscopy | Facility | 20 | 19 | $115.12 | $2,302 |
By year: 2022 $233K for 4,108 services; 2023 $210K for 3,826 services; 2024 $198K for 3,268 services.
Medicare prescription drug claims, 2024
In 2024, the drug Fred C Fowler prescribed most often to Medicare patients was Dicyclomine Hcl, with 533 prescriptions and refills. In total Fred C Fowler wrote 5,736 Medicare prescriptions that cost $4.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dicyclomine Hcl Generic | 533 | 887 | 182 | $10K |
| Omeprazole Generic | 441 | 890 | 126 | $4,888 |
| Pantoprazole Sodium Generic | 404 | 786 | 105 | $2,729 |
| Metoclopramide Hcl Generic | 315 | 403 | 94 | $1,435 |
| Linzess Linaclotide | 264 | 446 | 82 | $238K |
| Sucralfate Generic | 215 | 306 | 70 | $13K |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 171 | 171 | 169 | $11K |
| Bethanechol Chloride Generic | 165 | 269 | 45 | $7,865 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 135 | 152 | 41 | $4,910 |
| Clenpiq Sod Picosulf/Mag Ox/Citric Ac | 125 | 125 | 121 | $21K |
| Dexlansoprazole Dr Dexlansoprazole | 112 | 153 | 21 | $28K |
| Spironolactone Generic | 103 | 159 | 20 | $1,091 |
| Lubiprostone Generic | 100 | 139 | 38 | $12K |
| Famotidine Generic | 100 | 231 | 30 | $1,977 |
| Xifaxan Rifaximin | 99 | 99 | 18 | $322K |
Brand drugs: 1,610 claims; generic drugs: 4,126 claims; opioid claims: 13.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Fred C Fowler $235K ($235K in general payments such as food, travel and fees) from 24 companies. The largest payer was Salix Pharmaceuticals, a division of Bausch Health US, LLC with $65K.
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 87 | $65K |
| Madrigal Pharmaceuticals MDGL | 45 | $37K |
| Phathom Pharmaceuticals, Inc. PHAT | 60 | $34K |
| Novo Nordisk Inc NVO | 21 | $26K |
| Abbvie Inc. ABBV | 76 | $18K |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 10 | $15K |
| Lilly USA, LLC LLY | 26 | $12K |
| QOL Medical, LLC | 29 | $10K |
| Gilead Sciences, Inc. GILD | 33 | $9,764 |
| Evoke Pharma, Inc. EVOK | 10 | $6,720 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.